Search PubMed⌕ Search

Biomedical subjects

S Henderson

Publications and source records attributed to S Henderson.

184 records · Page 11Linked to original sources
PubMedDate not supplied

Divalproex loading in the treatment of cocaine dependence.

The current pilot project was designed to evaluate the safety and tolerability of a loading dose of divalproex (DVPX) in subjects with cocaine dependence. Seventeen cocaine-dependent subjects were enrolled in an eight-week, open-label trial of 20 mg/kg/day DVPX. Subjects were seen weekly and urine drug screens were obtained at each visit. Over the eight-week trial, craving intensity and frequency as well as reported time using cocaine decreased significantly. Retention in the current study was 79% at week four and 50% at week eight. The medication and dosing strategy was well tolerated. This pilot study indicates that DVPX loading is well tolerated and may be efficacious in the treatment of cocaine dependence. A placebo-controlled trial would be of interest.

Adolescent↗
PubMedDate not supplied

Passive immunotherapy of mice bearing Ehrlich ascites tumor expressing human, membrane-bound placental alkaline phosphatase.

The objective of our study was to test if a tumor expressing a transgene coding for a membrane-bound protein is amenable to immunotherapy by antibodies to the same protein. To this end, we have established an Ehrlich ascites tumor (EAT) cell line, EAT-DAP, stably expressing human, membrane-bound placental alkaline phosphatase (PLAP) by infecting EAT cells (EATC) with the retroviral vector DAP and selecting neomycin-resistant cells. EATC and EAT-DAP cells grew at similar rates in vitro, and produced ascites tumor in Swiss-Webster mice with similar efficiency. We have treated mice bearing EAT-DAP ascites tumor with a mouse monoclonal antibody to human PLAP or with a monoclonal antibody to human C proteins of the heterogenous ribonucleoprotein complex (hnRNP). The average survival of mice treated with anti-hnRNP was 16.4 +/- 1.1 days (n = 8). Treatment with anti-PLAP prolonged the survival of mice; in 4 mice average survival was 23.3 +/- 5.7 days. Four animals, however, survived for 60 days when they were killed and had no visible signs of tumor. These data support the notion that passive immunotherapy using antibodies against a membrane protein, expressed in tumor cells transduced by a viral vector coding for that protein, may be effective in controlling tumor growth.

Alkaline Phosphatase↗
PubMedDate not supplied

Heating patterns of the Helios ultrasound hyperthermia system.

Thermal dosimetry studies of the Helios ultrasound system were performed in a tissue-equivalent phantom and in porcine tissues in vivo. SAR distributions in the phantom demonstrate the adjustability of the power deposition pattern from the 50 cm diameter annular array of 30 transducers. Examples are given of well-localized SAR patterns (< 3 cm diameter) in the phantom, and of peripherally enhanced (doughnut-shaped) SAR patterns up to 10 cm in diameter at the focal plane. In vivo trials in porcine thigh muscle demonstrate the ability of the Helios system to produce regions of therapeutic heating (42-45 degrees C) as small as 20 cm3 and as large as 200 cm3 at depths of greater than 10 cm at a frequency of 0.5 MHz.

Animals↗